Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation

Cell stem cell(2021)10.1016/j.stem.2020.12.005Source: DataRank Database

Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation is a research paper published in Cell stem cell (2021). On theSindex it has a DataRank of 0. It has been cited 69 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access69 citations

Download PDF

Cite:

Linked data & code

geo bioproject gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (33 grants)Impact (FWCI 8.53)OA: greenTopics (30)Linked Datasets (20)DataCite Reuse (20)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Hua Zhou ORCID,Bettina Nadorp ORCID,Geraldine Cayanan ORCID,Xufeng Chen ORCID,Anna H. Yeaton ORCID

Live enrichment

PubMed:33450187 PMC:PMC8145876 OpenAlex:https://openalex.org/W3118303034

National Cancer Institute

Grant: R01CA216421

National Cancer Institute

Grant: 1P01CA229086

National Cancer Institute

Grant: R01CA228135

National Cancer Institute

Grant: R01CA202025

National Cancer Institute

Grant: 1R01CA194923

National Cancer Institute

Grant: P30CA016087-30

National Cancer Institute

Grant: R01CA149655

National Cancer Institute

Grant: R01CA133379

American Cancer Society

Grant: RSG-15-189-01-RMC

St. Baldrick's Foundation

Grant: 581357

Alexander S. Onassis Public Benefit Foundation

Grant: F ZP 036-1/2019-2020

NCI NIH HHS

Grant: P01 CA229086

NCI NIH HHS

Grant: R01 CA173636

NCI NIH HHS

Grant: R01 CA252239

NCI NIH HHS

Grant: T32 CA009161

NCI NIH HHS

Grant: R01 CA194923

NCI NIH HHS

Grant: R01 CA242020

NCI NIH HHS

Grant: P30 CA016087

NCI NIH HHS

Grant: R01 CA202027

NIGMS NIH HHS

Grant: T32 GM136542

NIGMS NIH HHS

Grant: T32 GM115313

National Institutes of Health

Grant: 5R01CA133379-08

The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.

National Institutes of Health

Grant: 1R01CA228135-01A1

Mechanisms of enhancer regulation in leukemia

National Institutes of Health

Grant: 1R01CA202025-01A1

Mapping cancer micro-environments for acute leukemia

National Institutes of Health

Grant: 5T32CA009161-30

TRAINING PROGRAM IN MOLECULAR ONCOLOGY AND IMMUNOLOGY

National Institutes of Health

Grant: 5R01CA216421-05

The cohesin complex as a tumor suppressor in myeloid leukemia

National Institutes of Health

Grant: 5P30CA016087-32

Experimental Pathology

National Institutes of Health

Grant: 1R01CA149655-01

Mechanisms of T cell leukemia induction and maintenance

National Institutes of Health

Grant: 1P01CA229086-01A1

The impact of changes in chromatin architecture on cancer phenotypes and tumor progression

National Institutes of Health

Stanford Genome Technology Center

Leukemia and Lymphoma Society

New York State Stem Cell Science

FWCI

8.53

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier Non-Commercial

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8145876

publisherhttps://api.elsevier.com/content/article/PII:S1934590920305890?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1934590920305890?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.stem.2020.12.005

Fields of Study

Acute Myeloid Leukemia ResearchCRISPR and Genetic EngineeringRNA Research and Splicing0301 basic medicine03 medical and health sciences

MeSH Terms

Antigens, SurfaceCell DifferentiationHematopoiesisHumansLeukemia, Myeloid, AcuteClustered Regularly Interspaced Short Palindromic Repeats

Keywords

BiologyMyeloid leukemiaMyeloidCellular differentiationEpigeneticsLeukemiaRegulatorCRISPRCell biologymicroRNACancer researchGeneGeneticsLeukemia, Myeloid, AcuteAntigens, SurfaceHumansCell DifferentiationClustered Regularly Interspaced Short Palindromic RepeatsHematopoiesis

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.24993727.v1figshare

Additional file 1 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.24993727figshare

Additional file 9 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666941.v1figshare

Additional file 9 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666941figshare

Additional file 10 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666944.v1figshare

Additional file 10 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666944figshare

Additional file 8 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666938.v1figshare

Additional file 7 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666935.v1figshare

Additional file 8 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666938figshare

Additional file 6 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666932figshare

Additional file 7 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666935figshare

Additional file 4 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666926figshare

Additional file 5 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666929.v1figshare

Additional file 5 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666929figshare

Additional file 6 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666932.v1figshare

Additional file 2 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.24993805figshare

Additional file 4 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666926.v1figshare

Additional file 2 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.24993805.v1figshare

Additional file 3 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666923figshare

Additional file 3 of RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9

10.6084/m9.figshare.26666923.v1figshare

Related Papers (8)

CRISPR-repressed toxin–antitoxin provides herd immunity against anti-CRISPR elements

Nature Chemical Biology(2024)

OpenAlex related

10.1038/s41589-024-01693-3

The advancements, challenges, and future implications of the CRISPR/Cas9 system in swine research

Journal of genetics and genomics/Journal of Genetics and Genomics(2021)

OpenAlex related

10.1016/j.jgg.2021.03.015

Using CRISPR/Cas9 Technology for Manipulating Cell Death Regulators

Methods in molecular biology(2016)

OpenAlex related

10.1007/978-1-4939-3581-9_18

Lymphoid to Myeloid Cell Trans-Differentiation Is Determined by C/EBPβ Structure and Post-Translational Modifications

PLoS ONE(2013)

OpenAlex related

10.1371/journal.pone.0065169

Down-Regulation of c-myc Gene Is not Obligatory for Growth Inhibition and Differentiation of Human Myeloid Leukemia Cells

PubMed(1993)

OpenAlex related

10.5281/zenodo.18338170

Regulation of c‐fos gene transcription and myeloid cell differentiation by acute myeloid leukemia 1 and acute myeloid leukemia‐MTG8, a chimeric leukemogenic derivative of acute myeloid leukemia 1

FEBS Letters(1999)

OpenAlex related

10.1016/s0014-5793(99)00190-8

The emerging role of CRISPR-Cas9 in molecular oncology

International Journal of Molecular and Immuno Oncology(2017)

OpenAlex related

10.18203/issn.2456-3994.intjmolimmunooncol20172641

Brief Introduction to CRISPR Cas9

(2022)

OpenAlex related

10.1007/978-3-030-98368-0_1

Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation

FAIR Checklist

Authors (14)

Funding (33 grants)

Impact

Open Access

Topics

Linked Datasets (20)

Annotations (Europe PMC)

Related Papers (8)